How They Won It: Greenberg Wins Stiefel Securities Verdict

Law360, New York (December 19, 2013, 4:42 PM EST) -- Greenberg Traurig LLP attorneys relied on flexibility in rebuffing an investor's $2.5 million suit against Stiefel Laboratories Inc. and its former CEO with a defense that focused on providing context and poking holes in the plaintiff's storyline — and could prove significant for related pending cases.

Lead defense attorneys Hilarie Bass and David A. Coulson said they were constantly making adjustments based on the case put forth by former Stiefel executive Robert I. Fried, who claimed that the pharmaceutical maker and several executives, including then-CEO Charles...
To view the full article, register now.